Zentalis Pharmaceuticals, Inc. short interest in 2025
In 2025, Zentalis Pharmaceuticals, Inc.'s disclosed short interest ran from 7.12% of shares outstanding on 15 Jan 2025 to 5.69% on 31 Dec 2025, a change of -1.43 percentage points. The year's high was 8.59% on 15 May 2025 and its low 5.69% on 31 Dec 2025, averaging 7.04% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 11.06 days on 15 Dec 2025. Full history: Zentalis Pharmaceuticals, Inc..
Cite this page
By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2025 in figures
- Start of year
- 7.12% (15 Jan 2025)
- End of year
- 5.69% (31 Dec 2025)
- Change
- -1.43 pp
- High
- 8.59% (15 May 2025)
- Low
- 5.69% (31 Dec 2025)
- Average
- 7.04%
- Highest days to cover
- 11.06 (15 Dec 2025)
- SEC filings marked
- 8
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2025 | 7.12% | 3.22 | |
| 31 Jan 2025 | 6.80% | 1.23 | |
| 14 Feb 2025 | 7.28% | 2.58 | |
| 28 Feb 2025 | 7.26% | 5.01 | |
| 14 Mar 2025 | 7.47% | 6.29 | |
| 31 Mar 2025 | 6.64% | 5.42 | 10-K filed, results (8-K) |
| 15 Apr 2025 | 7.33% | 6.12 | |
| 30 Apr 2025 | 8.11% | 7.51 | |
| 15 May 2025 | 8.59% | 8.59 | 10-Q filed, results (8-K) |
| 30 May 2025 | 8.19% | 9.08 | |
| 13 Jun 2025 | 7.93% | 5.31 | |
| 30 Jun 2025 | 7.06% | 2.97 | |
| 15 Jul 2025 | 6.64% | 4.34 | |
| 31 Jul 2025 | 6.56% | 8.64 | |
| 15 Aug 2025 | 6.19% | 6.82 | 10-Q filed, results (8-K) |
| 29 Aug 2025 | 6.22% | 4.65 | |
| 15 Sep 2025 | 6.30% | 7.42 | |
| 30 Sep 2025 | 6.12% | 6.05 | |
| 15 Oct 2025 | 6.84% | 6.69 | |
| 31 Oct 2025 | 6.92% | 7.02 | |
| 14 Nov 2025 | 7.04% | 7.21 | 10-Q filed, results (8-K) |
| 28 Nov 2025 | 7.10% | 10.09 | |
| 15 Dec 2025 | 7.61% | 11.06 | |
| 31 Dec 2025 | 5.69% | 4.04 |
See also: Zentalis Pharmaceuticals, Inc.'s full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.